A 18F-Labeled BF-227 Derivative as a Potential Radioligand for Imaging Dense Amyloid Plaques by Positron Emission Tomography

被引:0
作者
Shozo Furumoto
Nobuyuki Okamura
Katsutoshi Furukawa
Manabu Tashiro
Yoichi Ishikawa
Kentaro Sugi
Naoki Tomita
Masaaki Waragai
Ryuichi Harada
Tetsuro Tago
Ren Iwata
Kazuhiko Yanai
Hiroyuki Arai
Yukitsuka Kudo
机构
[1] Tohoku University School of Medicine,Department of Pharmacology
[2] Tohoku University,Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center
[3] Tohoku University,Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging and Cancer
[4] Tohoku University,Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center
[5] Tohoku University Hospital,Clinical Research, Innovation and Education Center
来源
Molecular Imaging and Biology | 2013年 / 15卷
关键词
Alzheimer’s disease; Amyloid; Early diagnosis; Positron emission tomography;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:497 / 506
页数:9
相关论文
共 84 条
[11]  
Kudo Y(2010)Imaging beta-amyloid burden in aging and dementia J Alzheimer’s Dis JAD 21 995-1003
[12]  
Okamura N(2011)Clinically different stages of Alzheimer’s disease associated by amyloid deposition with [ Ann Neurol 69 181-192
[13]  
Fodero-Tavoletti MT(2001)C]-PIB PET imaging Neuroscience 105 99-107
[14]  
Kudo Y(2004)Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease J Neurosci 24 2535-2541
[15]  
Klunk WE(2007)The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease J Nucl Med 48 553-561
[16]  
Engler H(2011)Styrylbenzoxazole derivatives for Eur J Nucl Med Mol Imaging 38 1702-1714
[17]  
Nordberg A(2009) imaging of amyloid plaques in the brain J Neurol Sci 285 100-108
[18]  
Vandenberghe R(2010)2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for Dement Geriatr Cogn Disord 30 101-111
[19]  
Van Laere K(1984) detection of dense amyloid plaques in Alzheimer’s disease patients Neurology 34 939-944
[20]  
Ivanoiu A(1999)Individualized quantification of brain beta-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls Arch Neurol 56 303-308